Healthcare


 Could This Strategic Overhaul Reshape a Key Player in the FTSE AIM 100 Index?

Could This Strategic Overhaul Reshape a Key Player in the FTSE AIM 100 Index?

May 12, 2025 01:31 PM BST| By Team Kalkine Media

Highlights,Venture Life Group has divested its manufacturing operations to streamline focus on consumer healthcare brands.,The sale is structured to support debt reduction and expansion into UK, US, and EU markets.,The company has entered a decade-lo...

 What’s Next for hVIVO in the FTSE AIM Sector Amidst Boardroom Changes?

What’s Next for hVIVO in the FTSE AIM Sector Amidst Boardroom Changes?

May 12, 2025 09:31 AM BST| By Team Kalkine Media

Highlights,hVIVO PLC (LSE:HVO), listed on the FTSE AIM All-Share Index, announces significant changes in its leadership structure.,Long-standing chair and co-founder Cathal Friel to step down, with interim chair duties assumed by Dr. Elaine Sullivan....

 How Is Optima Health Shaping the FTSE AIM Health & Wellbeing Sector?

How Is Optima Health Shaping the FTSE AIM Health & Wellbeing Sector?

May 12, 2025 08:30 AM BST| By Team Kalkine Media

Highlights,Optima Health PLC has expanded its UK and Irish footprint through multiple acquisitions.,The company secured a long-term subcontract for UK Armed Forces medical assessments.,Revenue growth was supported by organic initiatives and strategic...

 What’s Driving Market Attention Toward This FTSE AIM 100 Healthcare Stock?

What’s Driving Market Attention Toward This FTSE AIM 100 Healthcare Stock?

May 09, 2025 03:30 PM BST| By Team Kalkine Media

Highlights,Belluscura PLC initiated a strategic review to explore business-enhancing options, leading to increased market scrutiny.,The company recorded record monthly of its X-PLOR portable oxygen concentrator.,Upcoming commercial launch of the DISC...

 How Is Oxford BioDynamics Advancing Genomic Diagnostics on the FTSE AIM 100 Index?

How Is Oxford BioDynamics Advancing Genomic Diagnostics on the FTSE AIM 100 Index?

May 09, 2025 01:31 PM BST| By Team Kalkine Media

Highlights,Oxford BioDynamics receives ISO 15189 accreditation for its Oxford facility, strengthening its clinical testing infrastructure in the UK.,EpiSwitch CiRT and PSE test orders across Europe will now be processed in the UK, reducing turnaround...

 Optima Health provides a combination of strong defensive features and substantial growth opportunities.

Optima Health provides a combination of strong defensive features and substantial growth opportunities.

May 08, 2025 08:30 PM BST| By Team Kalkine Media

Highlights,Optima Health PLC operates in the healthcare sector, offering outsourced occupational health services across the UK and Ireland,The company maintains long-term contracts and a wide clinician network, supporting its scalable service model,R...

 FTSE Now: Polarean Imaging's Progress and Market Trends

FTSE Now: Polarean Imaging's Progress and Market Trends

May 08, 2025 01:30 PM BST| By Team Kalkine Media

Highlights,Polarean Imaging's revenue surged significantly, reflecting strong market acceptance.,Strategic cost management has extended cash runway into 2026, bolstering financial stability.,The company is set to capture a large share of the medical...

 How is Kromek Group PLC Performing in the Technology Sector on FTSE Now?

How is Kromek Group PLC Performing in the Technology Sector on FTSE Now?

May 08, 2025 01:30 PM BST| By Team Kalkine Media

Highlights,Kromek Group PLC (LSE: KMK) surpasses revenue and profit expectations for the fiscal year ending 30 April.,Advanced Imaging Division and significant contracts boost financial performance, including a key deal with Siemens Healthineers.,Int...

 How Is This FTSE Small Cap Imaging Firm Responding to US Market Pressures?

How Is This FTSE Small Cap Imaging Firm Responding to US Market Pressures?

May 08, 2025 09:30 AM BST| By Team Kalkine Media

Highlights,Polarean Imaging PLC (LSE: POLX), listed on the FTSE Small Cap index, maintains revenue projections despite funding constraints in the US academic sector.,Strategic collaborations and geographic expansion underpin sales momentum for its no...

 Could Optima’s Latest Move Propel ftse now Momentum Across Key Indexes

Could Optima’s Latest Move Propel ftse now Momentum Across Key Indexes

May 07, 2025 02:31 PM BST| By Team Kalkine Media

Highlights,ftse now,focus sharpens as Optima Health PLC (ticker OPT) enters new service territory, reflecting trends in the FTSE AIM All-Share, FTSE 250 and FTSE 100 indices,Acquisition introduces access to a broad network of corporate clients and sp...

 Are UK Pharma and Tech Stocks Shaping FTSE 100 Index Movements?

Are UK Pharma and Tech Stocks Shaping FTSE 100 Index Movements?

May 07, 2025 01:44 PM BST| By Team Kalkine Media

Highlights,UK pharmaceutical stocks saw declines amid global regulatory developments,Defense and tech sectors showed contrasting performances within FTSE indexes,Market volatility influenced long-maturity gilt sales discussions ahead of BOE meeting,P...

 Is Optima Health Strengthening Its FTSE 100 Live Position Through Strategic Acquisition?

Is Optima Health Strengthening Its FTSE 100 Live Position Through Strategic Acquisition?

May 06, 2025 09:30 AM BST| By Team Kalkine Media

Highlights,Optima Health PLC acquires Care first to expand its mental health services operations.,The move aligns with Optima’s long-term strategic growth within the healthcare sector.,Integration of new clients and employees reinforces Optima’s oper...

 Can Frontier IP’s ASF Vaccine Innovation Strengthen Biosecurity? | ftse 100 live Update

Can Frontier IP’s ASF Vaccine Innovation Strengthen Biosecurity? | ftse 100 live Update

May 06, 2025 09:30 AM BST| By Team Kalkine Media

Highlights,The Vaccine Group, a portfolio company of Frontier IP Group, begins animal testing for an ASF vaccine candidate.,The project is supported by The Pirbright Institute and the UK’s Biotechnology and Biological Sciences Research Council.,The v...

 How Is Itaconix Managing Tariff Impacts in the Detergent Polymers Market on the FTSE All Share and AIM?

How Is Itaconix Managing Tariff Impacts in the Detergent Polymers Market on the FTSE All Share and AIM?

May 06, 2025 07:30 AM BST| By Team Kalkine Media

Highlights,Itaconix reports strong detergent polymer demand early in the year amid changing global trade conditions.,Tariff changes have marginally affected input costs, but key raw materials remain relatively stable.,Strategic adjustments such as lo...

 Can Genflow Biosciences Drive Innovation in the Biotech Sector Amid FTSE All Share Trends?

Can Genflow Biosciences Drive Innovation in the Biotech Sector Amid FTSE All Share Trends?

May 06, 2025 07:30 AM BST| By Team Kalkine Media

Highlights,Genflow Biosciences (GENF) received regulatory clearance to start direct clinical trials with MASH patients.,Research expanded into Werner syndrome and sarcopenia, alongside a new proof-of-concept study in dogs.,Intellectual property advan...

 Is Nuformix’s Inhaled Therapy Advancing Amid FTSE 350 Innovation Trends?

Is Nuformix’s Inhaled Therapy Advancing Amid FTSE 350 Innovation Trends?

May 02, 2025 01:30 PM BST| By Team Kalkine Media

Highlights,Nuformix PLC posted widened losses and reduced cash reserves, while raising new funds through share subscriptions.,Discussions are ongoing for licensing its fibrosis-focused drug candidate, NXP002.,The company received regulatory support v...

 What is the Latest Development from IQ-AI Ltd in Medical Imaging?

What is the Latest Development from IQ-AI Ltd in Medical Imaging?

May 02, 2025 11:30 AM BST| By Team Kalkine Media

Highlights,IQ-AI Ltd (LSE:IQAI) is advancing in the medical imaging sector with a breakthrough therapy for glioblastoma.,The company’s subsidiary, Imaging Biometrics, has submitted an application for Breakthrough Therapy Designation for its gallium m...

 Is Totally PLC's Financial Stability in Question Amid Profit Revisions and Leadership Exit?

Is Totally PLC's Financial Stability in Question Amid Profit Revisions and Leadership Exit?

May 01, 2025 12:31 PM BST| By Team Kalkine Media

Highlights,Totally PLC reported a revised EBITDA outlook for the full year, citing lower margins and a phased contract completion.,The company's Chief Financial Officer resigned unexpectedly, prompting leadership changes during a sensitive period.,A...

 Could GSK’s FTSE 100 and All-Share Status Gain from Nucala Trial Breakthrough?

Could GSK’s FTSE 100 and All-Share Status Gain from Nucala Trial Breakthrough?

May 01, 2025 09:25 AM BST| By Team Kalkine Media

Could GSK’s FTSE 100 and All-Share Status Gain from Nucala Trial Breakthrough?

 What’s Behind Genus’s Twenty-Seven Percent Surge in the FTSE 250?

What’s Behind Genus’s Twenty-Seven Percent Surge in the FTSE 250?

April 30, 2025 06:30 PM BST| By Team Kalkine Media

What’s Behind Genus’s Twenty-Seven Percent Surge in the FTSE 250?

Recent Articles






Investing Tips

Previous Next